Page last updated: 2024-12-07

6'-o-methylguanosine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID96312
CHEMBL ID406852
SCHEMBL ID2143756
MeSH IDM0133909

Synonyms (30)

Synonym
7803-88-5
o-methylguanosine
o-methoxydeoxyguanosine
guanosine, o-methyl-
nsc 66381
6'-o-methylguanosine
brn 0703603
6-o-methylguanosine
CHEMBL406852
(2r,3r,4s,5r)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2r,3r,4s,5r)-2-(2-azanyl-6-methoxy-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2r,3r,4s,5r)-2-(2-amino-6-methoxy-9-purinyl)-5-(hydroxymethyl)oxolane-3,4-diol
A840412
SCHEMBL2143756
o6-methylguanosine
o(6)-methylguanosine
6-o-methyl guanosine
guanosine, 6-o-methyl-
AC-32355
(2r,3r,4s,5r)-2-(2-amino-6-methoxy-9h-purin-9-yl)-5-(hydroxymethyl)-tetrahydrofuran-3,4-diol
AKOS027439714
guanosine,6-o-methyl-
(2r,3r,4s,5r)-2-(2-amino-6-methoxy-9h-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Q15632797
HY-111648
CS-0089201
HD9 ,
2-amino-6-methoxy-9-b-d-ribofuranosyl-9h-purine
DTXSID10861265
PD102286
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID329451Inhibition of inosine and alanine-induced germination of Bacillus anthracis Sterne spore pre-incubated for 15 mins2007The Journal of biological chemistry, Apr-20, Volume: 282, Issue:16
Identification of an in vivo inhibitor of Bacillus anthracis spore germination.
AID584546Inhibition of inosine/L-alanine-induced Bacillus anthracis Sterne 34F2 spore germination pretreated for 15 mins before inosine/L-alanine challenge2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID612651Activity of recombinant human ADAL1 expressed in Escherichia coli by UV-spectrophotometry2011Journal of medicinal chemistry, Aug-25, Volume: 54, Issue:16
Adenosine deaminase-like protein 1 (ADAL1): characterization and substrate specificity in the hydrolysis of N(6)- or O(6)-substituted purine or 2-aminopurine nucleoside monophosphates.
AID329453Inhibition of cytopathic effect in Bacillus anthracis Sterne infected mouse RAW264.7 macrophage after 6 hrs by propidium iodide exclusion assay2007The Journal of biological chemistry, Apr-20, Volume: 282, Issue:16
Identification of an in vivo inhibitor of Bacillus anthracis spore germination.
AID584547Antibacterial activity against Bacillus anthracis Sterne 34F2 infected in mouse J774A.1 cells assessed as protection against bacteria-induced cytotoxicity using propidium iodide staining after 3 hrs measured every hours for up to 7 hrs2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID584550Cytotoxicity against mouse J774A1 cells2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.12)18.7374
1990's7 (21.21)18.2507
2000's13 (39.39)29.6817
2010's9 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.08 (24.57)
Research Supply Index3.58 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.71%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (94.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]